Amgen (JOBS) Says Vectibix Colon Cancer Trial Meets Goal

Bookmark and Share

Reuters -- Amgen Inc said on Thursday colon cancer patients lived significantly longer without their disease getting worse when treated initially with its drug, Vectibix, and chemotherapy, rather than with chemo alone.
MORE ON THIS TOPIC